Literature DB >> 24457138

Avian influenza A(H7N9) virus infection in pregnant woman, China, 2013.

Xian Qi, Lunbiao Cui, Ke Xu, Bin Wu, Fenyang Tang, Changjun Bao, Yefei Zhu, Ming-Hao Zhou, Hua Wang.   

Abstract

Entities:  

Keywords:  China; avian influenza A(H7N9) virus; influenza; influenza virus; pregnant woman; viruses

Mesh:

Substances:

Year:  2014        PMID: 24457138      PMCID: PMC3901503          DOI: 10.3201/eid2002.131109

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: In February 2013, human infection with reassortant avian influenza A(H7N9) virus occurred in eastern China. A total of 135 laboratory-confirmed cases and 44 deaths among case-patients have been reported as of August 11, 2013. Unlike infection with other H7 subtype viruses (e.g., H7N2, H7N3, and H7N7), which often cause mild-to-moderate-human disease (), infection with H7N9 subtype virus caused severe pneumonia and acute respiratory distress syndrome in most laboratory-confirmed case-patients (,). Pregnant women are particularly susceptible to severe complications from influenza (seasonal and pandemic), and have an increased risk for maternal death (). On March 30, 2013, a 25-year-old pregnant woman came to the outpatient department of a hospital in Zhenjiang, Jiangsu Province, China. She had cough and fever (temperature 38.0°C), which had begun 2 days earlier. She also reported mild myalgia and mild sore throat. The patient had no any underlying medical conditions and was at 17 weeks gestation, as estimated by ultrasound. On April 5, she was admitted to the respiratory department of the hospital with a temperature of 39.9°C, a leukocyte count of 7.9 ×109 cells/L, and a lymphocyte count of 0.7 × 109 cells/L. On April 6, she was transferred to the intensive care unit because of shortness of breath, respiratory failure, and loss of consciousness. She was given mechanical ventilation, broad-spectrum antimicrobial drugs, oseltamivir, gamma-globulin, antifibrotic therapy (glutathione), and nutritional support. Oseltamivir (150 mg/d, 2 times/d) had been administered during April 6–12. A chest radiograph showed extensive infiltrates of both lungs. On April 21, she regained consciousness, and her condition stabilized over the next few days. On April 23, she was extubated, transferred to the common ward, and given nasal oxygen supplementation and antimicrobial and antifibrotic drug therapy. Her condition improved gradually, and on May 14 she was discharged in good health without fetal abnormality. The fetus was monitored daily by using ultrasound to check the heart rate; fetal heart rate and activity were normal during hospitalization. The fetus continued to grow appropriately and was delivered by cesarean section at 35 weeks’ gestation on July 17 (length 48 cm, weight 3,300 g, and Apgars scores of 9 at 1 min and 10 at 5 min). The clinical timeline for the case-patient is shown in the Figure.
Figure

Clinical timeline for a pregnant woman infected with avian influenza A(H7N9) virus, China, 2013. ICU, intensive care unit; RT-PCR, reverse transcription PCR.

Clinical timeline for a pregnant woman infected with avian influenza A(H7N9) virus, China, 2013. ICU, intensive care unit; RT-PCR, reverse transcription PCR. The patient and her husband lived in a house with her husband’s parents. No live poultry were present in the residential district, but the husband’s parents worked as pork butchers in a live animal market ≈500 m from the residential district. Several kinds of live poultry (e.g., chicken, duck, pigeon, and quail) were sold in the market. During the 2 weeks before illness onset, the patient did not have contact with persons known to be febrile. However, during that time, she visited the live animal market once. Eighteen potential close contacts of the patient were identified (15 health care workers and 3 household members). Respiratory symptoms did not develop in any of these contacts during a 7-day surveillance period. Four methods were used for laboratory diagnosis: real-time reverse transcription PCR, virus isolation, full-genome sequencing, and modified hemagglutination inhibition assays. Clinical samples tested were 2 throat swab specimens obtained from the patient on April 6 and 7, 38 paired serum samples obtained from the patient and close contacts during the acute and convalescent phases of infection, and 6 environmental samples (2 avian feces samples and 4 poultry cage specimens obtained from the live animal market that the patient visited). Throat swab specimens from patient were positive for the hemagglutinin (HA) and neuraminidase genes of avian influenza A (H7N9) virus. Of 6 environmental samples, 5 were positive for (H7N9) virus HA genes. No (H7N9) virus HA antibodies were detected from paired serum samples from all 18 close contacts. Two virus strains were isolated: 1 from a patient specimen (A/Zhenjiang/1/2013) and 1 from a chicken cage specimen (A/environment/Zhenjiang/4/2013) (GenBank accession nos. KF007057–KF007064 and KF007009–KF007016, respectively). Genome comparison showed that isolates had a nucleotide identity of 96.8%–99.8%, indicating an amino acid identity of 98·2%–99·6%. Phylogenetic analysis showed that 5 genes (HA, nucleoprotein, neuraminidase, matrix, and nonstructural protein) of the 2 isolates belonged to the same clade. However, the 3 polymerase genes (polymerase basic 1, polymerase basic 2, and polymerase acidic) clustered in a different clade. These results suggested that the 2 strains originated from an independent reassortment mechanism and that the H7N9 subtype viruses had undergone genetic reassortment to generate multiple novel genotypes in China. According to epidemiologic and clinical data for infections with avian influenza A(H7N9) virus, most patients with severe illness, including severe pneumonia and acute respiratory distress syndrome, were elderly men with underlying medical conditions (,). Our findings suggest that pregnancy might be a risk factor for clinically severe influenza in young women infected with H7N9 subtype virus.
  4 in total

1.  Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States.

Authors:  Alicia M Siston; Sonja A Rasmussen; Margaret A Honein; Alicia M Fry; Katherine Seib; William M Callaghan; Janice Louie; Timothy J Doyle; Molly Crockett; Ruth Lynfield; Zack Moore; Caleb Wiedeman; Madhu Anand; Laura Tabony; Carrie F Nielsen; Kirsten Waller; Shannon Page; Jeannie M Thompson; Catherine Avery; Chasisity Brown Springs; Timothy Jones; Jennifer L Williams; Kim Newsome; Lyn Finelli; Denise J Jamieson
Journal:  JAMA       Date:  2010-04-21       Impact factor: 56.272

2.  Clinical findings in 111 cases of influenza A (H7N9) virus infection.

Authors:  Hai-Nv Gao; Hong-Zhou Lu; Bin Cao; Bin Du; Hong Shang; Jian-He Gan; Shui-Hua Lu; Yi-Da Yang; Qiang Fang; Yin-Zhong Shen; Xiu-Ming Xi; Qin Gu; Xian-Mei Zhou; Hong-Ping Qu; Zheng Yan; Fang-Ming Li; Wei Zhao; Zhan-Cheng Gao; Guang-Fa Wang; Ling-Xiang Ruan; Wei-Hong Wang; Jun Ye; Hui-Fang Cao; Xing-Wang Li; Wen-Hong Zhang; Xu-Chen Fang; Jian He; Wei-Feng Liang; Juan Xie; Mei Zeng; Xian-Zheng Wu; Jun Li; Qi Xia; Zhao-Chen Jin; Qi Chen; Chao Tang; Zhi-Yong Zhang; Bao-Min Hou; Zhi-Xian Feng; Ji-Fang Sheng; Nan-Shan Zhong; Lan-Juan Li
Journal:  N Engl J Med       Date:  2013-05-22       Impact factor: 91.245

3.  Human infection with a novel avian-origin influenza A (H7N9) virus.

Authors:  Rongbao Gao; Bin Cao; Yunwen Hu; Zijian Feng; Dayan Wang; Wanfu Hu; Jian Chen; Zhijun Jie; Haibo Qiu; Ke Xu; Xuewei Xu; Hongzhou Lu; Wenfei Zhu; Zhancheng Gao; Nijuan Xiang; Yinzhong Shen; Zebao He; Yong Gu; Zhiyong Zhang; Yi Yang; Xiang Zhao; Lei Zhou; Xiaodan Li; Shumei Zou; Ye Zhang; Xiyan Li; Lei Yang; Junfeng Guo; Jie Dong; Qun Li; Libo Dong; Yun Zhu; Tian Bai; Shiwen Wang; Pei Hao; Weizhong Yang; Yanping Zhang; Jun Han; Hongjie Yu; Dexin Li; George F Gao; Guizhen Wu; Yu Wang; Zhenghong Yuan; Yuelong Shu
Journal:  N Engl J Med       Date:  2013-04-11       Impact factor: 91.245

Review 4.  Past, present, and possible future human infection with influenza virus A subtype H7.

Authors:  Jessica A Belser; Carolyn B Bridges; Jacqueline M Katz; Terrence M Tumpey
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

  4 in total
  3 in total

Review 1.  The pandemic potential of avian influenza A(H7N9) virus: a review.

Authors:  W D Tanner; D J A Toth; A V Gundlapalli
Journal:  Epidemiol Infect       Date:  2015-07-24       Impact factor: 4.434

Review 2.  Hormonal Regulation of Physiology, Innate Immunity and Antibody Response to H1N1 Influenza Virus Infection During Pregnancy.

Authors:  Elizabeth Q Littauer; Ioanna Skountzou
Journal:  Front Immunol       Date:  2018-10-29       Impact factor: 7.561

3.  Fatal avian influenza A(H5N1) infection in a 36-week pregnant woman survived by her newborn in Sóc Trăng Province, Vietnam, 2012.

Authors:  Tuan Van Le; Lan T Phan; Khanh H K Ly; Long T Nguyen; Hieu T Nguyen; Ngan T T Ho; Tung X Trinh; Nguyen N Tran Minh
Journal:  Influenza Other Respir Viruses       Date:  2019-02-27       Impact factor: 4.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.